A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
